In 2019, the market size of Oxytocic Pharmaceutical is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, ...
$3,280.00 14 June, 2019 | QYResearch
Global (United States, European Union and China) Oxytocic Pharmaceutical Market Research Report 2019-2025
$3,280.00 | 14 June, 2019 | QYResearch
In 2019, the market size of Oxytocic Pharmaceutical is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while ...
Global (United States, European Union and China) Liothyronine Market Research Report 2019-2025
In 2019, the market size of Liothyronine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market ...
$3,280.00 14 June, 2019 | QYResearch
Global (United States, European Union and China) Liothyronine Market Research Report 2019-2025
$3,280.00 | 14 June, 2019 | QYResearch
In 2019, the market size of Liothyronine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, t...
Global Glycobiology Market Insights, Forecast to 2025
Glycobiology is a monthly peer-reviewed scientific journal covering all aspects of the field of glycobiology and the official journal of the Society for Glyc...
$3,900.00 14 June, 2019 | QYResearch
Global Glycobiology Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Glycobiology is a monthly peer-reviewed scientific journal covering all aspects of the field of glycobiology and the official journal of the Societ...
Global Clofarabine Market Insights, Forecast to 2025
Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under ...
$3,900.00 14 June, 2019 | QYResearch
Global Clofarabine Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marke...
Global Elliotts B Solution Market Insights, Forecast to 2025
Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of men...
$3,900.00 14 June, 2019 | QYResearch
Global Elliotts B Solution Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatm...
Global Erwinia L-Asparaginase Drugs Market Insights, Forecast to 2025
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's ...
$3,900.00 14 June, 2019 | QYResearch
Global Erwinia L-Asparaginase Drugs Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Global Imatinib Mesylate Drugs Market Insights, Forecast to 2025
Imatinib is a medication used to treat cancer. The global Imatinib Mesylate Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by...
$3,900.00 14 June, 2019 | QYResearch
Global Imatinib Mesylate Drugs Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Imatinib is a medication used to treat cancer. The global Imatinib Mesylate Drugs market is valued at xx million US$ in 2018 and will reach xx mill...
Global Iclusig Market Insights, Forecast to 2025
Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acut...
$3,900.00 14 June, 2019 | QYResearch
Global Iclusig Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive ...
Global Vincristine Sulfate Liposome Injection Market Insights, Forecast to 2025
Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The globa...
$3,900.00 14 June, 2019 | QYResearch
Global Vincristine Sulfate Liposome Injection Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration....
Global Xatmep Market Insights, Forecast to 2025
Xatmep is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortion...
$3,900.00 14 June, 2019 | QYResearch
Global Xatmep Market Insights, Forecast to 2025
$3,900.00 | 14 June, 2019 | QYResearch
Xatmep is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medica...